AEON Biopharma, Inc. Operating Lease Right-of-Use Assets
AEON Biopharma, Inc. (AEON) had Operating Lease Right-of-Use Assets of $931.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-12
- 2026-06-30: Operating Lease, Right-of-Use Asset $931.00K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $992.00K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $1.05M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $1.11M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $931.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $992.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.05M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $1.11M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $1.17M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $1.23M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.29M 10-K · filed 2026-03-30 |
| 2024-09-30 | $1.35M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.40M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $198.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $262.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | $323.00K 10-Q/A · filed 2024-03-29 |
| 2022-12-31 | $475.00K 10-K/A · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |